Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 05, 2019 Filed Sep 16, 2019 19:58 UTC Amendment |
Prause BurkhardPres. & CEO, Bruker EST
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,718 | $0.00 Strike: $20.68 | $0.00 |
DisclosureSEC source: 0001179110-19-010357 · edgar.xml · derivative · entry 5 Prause Burkhard · CIK 0001544726 · Pres. & CEO, Bruker EST 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,718 shares Expires 2024-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The original Form 4 omitted the cash exercise of the three options for a total of 15,702 shares of common stock and therefore also reported an incorrect number of total shares owned in Column 5 of the line item disclosing the sale transaction. F2 · derivative.exercise_date: The option vested in four approximately equal annual installments on August 8, 2015, 2016, 2017 and 2018. Read SEC document |
| September 05, 2019 Filed Sep 16, 2019 19:58 UTC Amendment |
Prause BurkhardPres. & CEO, Bruker EST
|
Exercise / conversionCommon Stock | 2,000 | $22.19 | $44,380.00 |
DisclosureSEC source: 0001179110-19-010357 · edgar.xml · nonDerivative · entry 3 Prause Burkhard · CIK 0001544726 · Pres. & CEO, Bruker EST 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,742 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The original Form 4 omitted the cash exercise of the three options for a total of 15,702 shares of common stock and therefore also reported an incorrect number of total shares owned in Column 5 of the line item disclosing the sale transaction. Read SEC document |
| September 05, 2019 Filed Sep 16, 2019 19:58 UTC Amendment |
Prause BurkhardPres. & CEO, Bruker EST
|
Exercise / conversionCommon Stock | 9,984 | $19.82 | $197,882.88 |
DisclosureSEC source: 0001179110-19-010357 · edgar.xml · nonDerivative · entry 2 Prause Burkhard · CIK 0001544726 · Pres. & CEO, Bruker EST 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,742 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The original Form 4 omitted the cash exercise of the three options for a total of 15,702 shares of common stock and therefore also reported an incorrect number of total shares owned in Column 5 of the line item disclosing the sale transaction. Read SEC document |
| September 05, 2019 Filed Sep 16, 2019 19:58 UTC Amendment |
Prause BurkhardPres. & CEO, Bruker EST
|
Exercise / conversionCommon Stock | 3,718 | $20.68 | $76,888.24 |
DisclosureSEC source: 0001179110-19-010357 · edgar.xml · nonDerivative · entry 1 Prause Burkhard · CIK 0001544726 · Pres. & CEO, Bruker EST 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,758 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The original Form 4 omitted the cash exercise of the three options for a total of 15,702 shares of common stock and therefore also reported an incorrect number of total shares owned in Column 5 of the line item disclosing the sale transaction. Read SEC document |
| August 10, 2019 Filed Aug 13, 2019 21:33 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
Tax withholdingCommon Stock | 2,084 | $39.91 | $83,172.44 |
DisclosureSEC source: 0001179110-19-009474 · edgar.xml · nonDerivative · entry 2 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,004 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
| August 09, 2019 Filed Aug 13, 2019 21:33 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
Tax withholdingCommon Stock | 1,754 | $41.01 | $71,931.54 |
DisclosureSEC source: 0001179110-19-009474 · edgar.xml · nonDerivative · entry 1 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,088 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 15:40 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
GrantStock option (Right to Buy) · Derivative | 59,523 | $0.00 Strike: $46.15 | $0.00 |
DisclosureSEC source: 0001179110-19-009369 · edgar.xml · derivative · entry 8 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,523 Underlying: Common Stock · 59,523 shares Expires 2024-08-08 F3 · derivative.exercise_date: The option vests in four approximately equal annual installments on the anniversary of the grant date, commencing August 8, 2020. Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 15:40 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
GrantCommon Stock | 51,598 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-009369 · edgar.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,042,628 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in four approximately equal annual installments on the anniversary of the grant date, commencing August 8, 2020. Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 15:40 UTC |
Herman Gerald NVice President, CFO
|
GrantStock Option (Right to Buy) · Derivative | 11,344 | $0.00 Strike: $41.95 | $0.00 |
DisclosureSEC source: 0001179110-19-009368 · edgar.xml · derivative · entry 2 Herman Gerald N · CIK 0001327294 · Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,344 Underlying: Common Stock · 11,344 shares Expires 2029-08-08 F2 · derivative.exercise_date: The option vests in four approximately equal annual installments on the anniversary of the grant date, commencing August 8, 2020. Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 15:40 UTC |
Herman Gerald NVice President, CFO
|
GrantCommon Stock | 9,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-009368 · edgar.xml · nonDerivative · entry 1 Herman Gerald N · CIK 0001327294 · Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,263 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in four approximately equal annual installments on the anniversary of the grant date, commencing August 8, 2020. Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 15:39 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
GrantStock Option (Right to Buy) · Derivative | 19,924 | $0.00 Strike: $41.95 | $0.00 |
DisclosureSEC source: 0001179110-19-009367 · edgar.xml · derivative · entry 2 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,924 Underlying: Common Stock · 19,924 shares Expires 2029-08-08 F2 · derivative.exercise_date: The option vests in four approximately equal annual installments on the anniversary of the grant date, commencing August 8, 2020. Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 15:39 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
GrantCommon Stock | 17,271 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-009367 · edgar.xml · nonDerivative · entry 1 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,842 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in four approximately equal annual installments on the anniversary of the grant date, commencing August 8, 2020. Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 15:36 UTC |
Prause BurkhardPres. & CEO, Bruker EST
|
GrantStock Option (Right to Buy) · Derivative | 3,806 | $0.00 Strike: $41.95 | $0.00 |
DisclosureSEC source: 0001179110-19-009364 · edgar.xml · derivative · entry 2 Prause Burkhard · CIK 0001544726 · Pres. & CEO, Bruker EST 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,806 Underlying: Common Stock · 3,806 shares Expires 2029-08-08 F2 · derivative.exercise_date: The option vests in four approximately equal annual installments on the anniversary of the grant date, commencing August 8, 2020. Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 15:36 UTC |
Prause BurkhardPres. & CEO, Bruker EST
|
GrantCommon Stock | 3,299 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-009364 · edgar.xml · nonDerivative · entry 1 Prause Burkhard · CIK 0001544726 · Pres. & CEO, Bruker EST 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,040 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in four approximately equal annual installments on the anniversary of the grant date, commencing August 8, 2020. Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 15:38 UTC |
Srega JuergenGroup President Bruker CALID
|
GrantStock Option (Right to Buy) · Derivative | 12,994 | $0.00 Strike: $41.95 | $0.00 |
DisclosureSEC source: 0001179110-19-009366 · edgar.xml · derivative · entry 2 Srega Juergen · CIK 0001569832 · Group President Bruker CALID 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,994 Underlying: Common Stock · 12,994 shares Expires 2029-08-08 F2 · derivative.exercise_date: The option vests in four approximately equal annual installments on the anniversary of the grant date, commencing August 8, 2020. Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 15:38 UTC |
Srega JuergenGroup President Bruker CALID
|
GrantCommon Stock | 11,264 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-009366 · edgar.xml · nonDerivative · entry 1 Srega Juergen · CIK 0001569832 · Group President Bruker CALID 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,529 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in four approximately equal annual installments on the anniversary of the grant date, commencing August 8, 2020. Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 15:37 UTC |
Busse FalkoPresident, BioSpin Group
|
GrantStock Option (Right to Buy) · Derivative | 4,641 | $0.00 Strike: $41.95 | $0.00 |
DisclosureSEC source: 0001179110-19-009365 · edgar.xml · derivative · entry 2 Busse Falko · CIK 0001739999 · President, BioSpin Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,641 Underlying: Common Stock · 4,641 shares Expires 2029-08-08 F2 · derivative.exercise_date: The option vests in four approximately equal annual installments on the anniversary of the grant date, commencing August 8, 2020. Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 15:37 UTC |
Busse FalkoPresident, BioSpin Group
|
GrantCommon Stock | 4,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-009365 · edgar.xml · nonDerivative · entry 1 Busse Falko · CIK 0001739999 · President, BioSpin Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,181 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in four approximately equal annual installments on the anniversary of the grant date, commencing August 8, 2020. Read SEC document |
| August 07, 2019 Filed Aug 8, 2019 19:51 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
Tax withholdingCommon Stock | 1,680 | $41.71 | $70,072.80 |
DisclosureSEC source: 0001179110-19-009303 · edgar.xml · nonDerivative · entry 1 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,571 Read SEC document |
| June 03, 2019 Filed Jun 3, 2019 20:06 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
SaleCommon Stock | 400,000 | $41.48 | $16,591,200.00 |
DisclosureSEC source: 0001179110-19-006980 · edgar.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Former Spouse Disclosed balance after: 1,046,499 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.35 to $41.93, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: The reporting person disclaims beneficial ownership of 1,446,499 shares held by the reporting person's former spouse, inclusive of the 400,000 shares sold in the transactions reported herein, 1,042 shares held by the reporting person's spouse, 7,400 shares held by the reporting person's adult son and 6,920 shares held by the reporting person's adult daughter, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| May 30, 2019 Filed May 31, 2019 21:01 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
SaleCommon Stock | 84,295 | $41.48 | $3,496,295.29 |
DisclosureSEC source: 0001179110-19-006923 · edgar.xml · nonDerivative · entry 3 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Former Spouse Disclosed balance after: 1,446,499 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.29 to $41.78, inclusive. F4 · balance_after: The reporting person disclaims beneficial ownership of 1,846,499 shares held by the reporting person's former spouse, inclusive of the 400,000 shares sold in the transactions reported herein, 1,042 shares held by the reporting person's spouse, 7,400 shares held by the reporting person's adult son and 6,920 shares held by the reporting person's adult daughter, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| May 29, 2019 Filed May 31, 2019 21:01 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
SaleCommon Stock | 2,000 | $42.31 | $84,613.60 |
DisclosureSEC source: 0001179110-19-006923 · edgar.xml · nonDerivative · entry 2 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Former Spouse Disclosed balance after: 1,530,794 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.12 to $42.60, inclusive. F4 · balance_after: The reporting person disclaims beneficial ownership of 1,846,499 shares held by the reporting person's former spouse, inclusive of the 400,000 shares sold in the transactions reported herein, 1,042 shares held by the reporting person's spouse, 7,400 shares held by the reporting person's adult son and 6,920 shares held by the reporting person's adult daughter, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| May 29, 2019 Filed May 31, 2019 21:01 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
SaleCommon Stock | 313,705 | $41.47 | $13,010,632.54 |
DisclosureSEC source: 0001179110-19-006923 · edgar.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Former Spouse Disclosed balance after: 1,532,794 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.115 to $42.11, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (1), (2) and (3) to this Form 4. F4 · balance_after: The reporting person disclaims beneficial ownership of 1,846,499 shares held by the reporting person's former spouse, inclusive of the 400,000 shares sold in the transactions reported herein, 1,042 shares held by the reporting person's spouse, 7,400 shares held by the reporting person's adult son and 6,920 shares held by the reporting person's adult daughter, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| May 15, 2019 Filed May 17, 2019 13:10 UTC |
Kastner Marc ADirector
|
SaleCommon Stock | 1,374 | $41.79 | $57,413.00 |
DisclosureSEC source: 0001179110-19-006211 · edgar.xml · nonDerivative · entry 1 Kastner Marc A · CIK 0001570183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,811 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.75 to $41.87, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 07, 2019 Filed Jan 10, 2019 17:01 UTC |
ROSENTHAL BOBDirector
|
GrantCommon Stock | 4,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-000642 · edgar.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,185 F1 · shares: Shares are represented by restricted stock units. Shares of common stock vest in one installment on January 7, 2020. Read SEC document |
| January 07, 2019 Filed Jan 10, 2019 16:51 UTC |
Perkins Adelene QDirector
|
GrantCommon Stock | 4,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-000640 · edgar.xml · nonDerivative · entry 1 Perkins Adelene Q · CIK 0001375124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,364 F1 · shares: Shares are represented by restricted stock units. Shares of common stock vest in one installment on January 7, 2020. Read SEC document |
| January 07, 2019 Filed Jan 10, 2019 17:00 UTC |
Requardt Hermann FritzDirector
|
GrantCommon Stock | 4,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-000641 · edgar.xml · nonDerivative · entry 1 Requardt Hermann Fritz · CIK 0001651105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,185 F1 · shares: Shares are represented by restricted stock units. Shares of common stock vest in one installment on January 7, 2020. Read SEC document |
| January 07, 2019 Filed Jan 10, 2019 16:49 UTC |
PACKER RICHARD ADirector
|
GrantCommon Stock | 4,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-000639 · edgar.xml · nonDerivative · entry 1 PACKER RICHARD A · CIK 0001237765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,292.018 F1 · shares: Shares are represented by restricted stock units. Shares of common stock vest in one installment on January 7, 2020. Read SEC document |
| January 07, 2019 Filed Jan 10, 2019 16:48 UTC |
ORNELL JOHN ADirector
|
GrantCommon Stock | 4,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-000638 · edgar.xml · nonDerivative · entry 1 ORNELL JOHN A · CIK 0001186875 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,185 F1 · shares: Shares are represented by restricted stock units. Shares of common stock vest in one installment on January 7, 2020. Read SEC document |
| January 07, 2019 Filed Jan 10, 2019 16:46 UTC |
LINTON WILLIAM ADirector
|
GrantCommon Stock | 4,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-000637 · edgar.xml · nonDerivative · entry 1 LINTON WILLIAM A · CIK 0001243154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,935 F1 · shares: Shares are represented by restricted stock units. Shares of common stock vest in one installment on January 7, 2020. Read SEC document |
| January 07, 2019 Filed Jan 10, 2019 16:45 UTC |
Kastner Marc ADirector
|
GrantCommon Stock | 4,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-000636 · edgar.xml · nonDerivative · entry 1 Kastner Marc A · CIK 0001570183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,185 F1 · shares: Shares are represented by restricted stock units. Shares of common stock vest in one installment on January 7, 2020. Read SEC document |
| January 07, 2019 Filed Jan 10, 2019 16:44 UTC |
Martin Gilles Gerard JeanDirector
|
GrantCommon Stock | 4,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-000635 · edgar.xml · nonDerivative · entry 1 Martin Gilles Gerard Jean · CIK 0001597047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,185 F1 · shares: Shares are represented by restricted stock units. Shares of common stock vest in one installment on January 7, 2020. Read SEC document |
| January 07, 2019 Filed Jan 10, 2019 16:42 UTC |
Friend Cynthia MDirector
|
GrantCommon Stock | 4,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-000634 · edgar.xml · nonDerivative · entry 1 Friend Cynthia M · CIK 0001675108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,185 F1 · shares: Shares are represented by restricted stock units. Shares of common stock vest in one installment on January 7, 2020. Read SEC document |
| November 20, 2018 Filed Nov 26, 2018 19:23 UTC |
PACKER RICHARD ADirector
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 6,000 | $0.00 Strike: $4.13 | $0.00 |
DisclosureSEC source: 0001179110-18-013171 · edgar.xml · derivative · entry 2 PACKER RICHARD A · CIK 0001237765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2019-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2018 Filed Nov 26, 2018 19:23 UTC |
PACKER RICHARD ADirector
|
Exercise / conversionCommon Stock | 6,000 | $4.13 | $24,780.00 |
DisclosureSEC source: 0001179110-18-013171 · edgar.xml · nonDerivative · entry 1 PACKER RICHARD A · CIK 0001237765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,158.018 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2018 Filed Nov 8, 2018 21:00 UTC |
LINTON WILLIAM ADirector
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 6,000 | $0.00 Strike: $4.13 | $0.00 |
DisclosureSEC source: 0001179110-18-012666 · edgar.xml · derivative · entry 2 LINTON WILLIAM A · CIK 0001243154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2019-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2018 Filed Nov 8, 2018 21:00 UTC |
LINTON WILLIAM ADirector
|
Exercise / conversionCommon Stock | 6,000 | $4.13 | $24,780.00 |
DisclosureSEC source: 0001179110-18-012666 · edgar.xml · nonDerivative · entry 1 LINTON WILLIAM A · CIK 0001243154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,801 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2018 Filed Aug 13, 2018 19:58 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
Tax withholdingCommon Stock | 3,095 | $33.91 | $104,951.45 |
DisclosureSEC source: 0001179110-18-010536 · edgar.xml · nonDerivative · entry 2 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,251 Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 20:03 UTC |
Srega JuergenGroup President Bruker CALID
|
GrantStock Option (Right to Buy) · Derivative | 14,801 | $0.00 Strike: $34.02 | $0.00 |
DisclosureSEC source: 0001179110-18-010540 · edgar.xml · derivative · entry 2 Srega Juergen · CIK 0001569832 · Group President Bruker CALID 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,801 Underlying: Common Stock · 14,801 shares Expires 2028-08-09 F2 · derivative.exercise_date: The option vests in four approximately equal annual installments on the anniversary of the grant date, commencing August 9, 2019. Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 20:03 UTC |
Srega JuergenGroup President Bruker CALID
|
GrantCommon Stock | 13,228 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-010540 · edgar.xml · nonDerivative · entry 1 Srega Juergen · CIK 0001569832 · Group President Bruker CALID 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,265 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in four approximately equal annual installments on the anniversary of the grant date, commencing August 9, 2019. Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 20:02 UTC |
Herman Gerald NVice President, CFO
|
GrantStock Option (Right to Buy) · Derivative | 11,594 | $0.00 Strike: $34.02 | $0.00 |
DisclosureSEC source: 0001179110-18-010539 · edgar.xml · derivative · entry 2 Herman Gerald N · CIK 0001327294 · Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,594 Underlying: Common Stock · 11,594 shares Expires 2028-08-09 F2 · derivative.exercise_date: The option vests in four approximately equal annual installments on the anniversary of the grant date, commencing August 9, 2019. Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 20:02 UTC |
Herman Gerald NVice President, CFO
|
GrantCommon Stock | 10,362 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-010539 · edgar.xml · nonDerivative · entry 1 Herman Gerald N · CIK 0001327294 · Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,429 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in four approximately equal annual installments on the anniversary of the grant date, commencing August 9, 2019. Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 20:00 UTC |
Busse FalkoPresident, BioSpin Group
|
GrantStock Option (Right to Buy) · Derivative | 4,384 | $0.00 Strike: $34.02 | $0.00 |
DisclosureSEC source: 0001179110-18-010538 · edgar.xml · derivative · entry 2 Busse Falko · CIK 0001739999 · President, BioSpin Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,384 Underlying: Common Stock · 4,384 shares Expires 2028-08-09 F2 · derivative.exercise_date: The option vests in four approximately equal annual installments on the anniversary of the grant date, commencing August 9, 2019. Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 20:00 UTC |
Busse FalkoPresident, BioSpin Group
|
GrantCommon Stock | 3,919 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-010538 · edgar.xml · nonDerivative · entry 1 Busse Falko · CIK 0001739999 · President, BioSpin Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,158 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in four approximately equal annual installments on the anniversary of the grant date, commencing August 9, 2019. Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 19:58 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
GrantStock Option (Right to Buy) · Derivative | 22,695 | $0.00 Strike: $34.02 | $0.00 |
DisclosureSEC source: 0001179110-18-010536 · edgar.xml · derivative · entry 3 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,695 Underlying: Common Stock · 22,695 shares Expires 2028-08-09 F2 · derivative.exercise_date: The option vests in four approximately equal annual installments on the anniversary of the grant date, commencing August 9, 2019. Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 19:58 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
GrantCommon Stock | 20,283 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-010536 · edgar.xml · nonDerivative · entry 1 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,346 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in four approximately equal annual installments on the anniversary of the grant date, commencing August 9, 2019. Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 19:59 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
GrantStock option (Right to Buy) · Derivative | 68,454 | $0.00 Strike: $37.42 | $0.00 |
DisclosureSEC source: 0001179110-18-010537 · edgar.xml · derivative · entry 8 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,454 Underlying: Common Stock · 68,454 shares Expires 2023-08-09 F3 · derivative.exercise_date: The option vests in four approximately equal annual installments on the anniversary of the grant date, commencing August 9, 2019. Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 19:59 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
GrantCommon Stock | 61,178 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-010537 · edgar.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,991,030 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in four approximately equal annual installments on the anniversary of the grant date, commencing August 9, 2019. Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 19:58 UTC |
Prause BurkhardPres. & CEO, Bruker EST
|
GrantStock Option (Right to Buy) · Derivative | 4,332 | $0.00 Strike: $34.02 | $0.00 |
DisclosureSEC source: 0001179110-18-010535 · edgar.xml · derivative · entry 2 Prause Burkhard · CIK 0001544726 · Pres. & CEO, Bruker EST 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,332 Underlying: Common Stock · 4,332 shares Expires 2028-08-09 F2 · derivative.exercise_date: The option vests in four approximately equal annual installments on the anniversary of the grant date, commencing August 9, 2019. Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 19:58 UTC |
Prause BurkhardPres. & CEO, Bruker EST
|
GrantCommon Stock | 3,872 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-010535 · edgar.xml · nonDerivative · entry 1 Prause Burkhard · CIK 0001544726 · Pres. & CEO, Bruker EST 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,741 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in four approximately equal annual installments on the anniversary of the grant date, commencing August 9, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.